Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pemetrexed and LBH589 in Previously-Treated Patients With Advanced Non-Small Cell Lung Cancer

NCT00907179 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00907179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00907179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pemetrexed and LBH589 in Previously-Treated Patients With Advanced Non-Small Cell Lung Cancer
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Terminated
Start date
July 31, 2009
Completion date
July 31, 2015
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer